Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO) Financial Statements


Abeona Therapeutics Financial Overview

Abeona Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.507; its P/E ratio is -0.88; Abeona Therapeutics is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue-$ 68.00K$ 0.00$ 1.00M$ 346.00K
Gross Profit-$ 209.00K$ 0.00$ 650.00K-
EBIT$ 15.07M$ -950.00K$ -9.33M$ -7.98M$ -20.59M
EBITDA$ 15.84M$ -1.65M$ -8.24M$ -6.61M$ -19.48M
Net Income Common Stockholders$ 14.97M$ -1.04M$ -9.48M$ -12.08M$ -20.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.36M$ 52.15M$ 18.17M$ 20.10M$ 31.32M
Total Assets$ 53.34M$ 64.21M$ 38.76M$ 44.72M$ 55.17M
Total Debt$ 7.32M$ 7.63M$ 8.29M$ 8.54M$ 9.10M
Net Debt$ -33.05M$ -44.52M$ -9.87M$ -11.56M$ -22.22M
Total Liabilities$ 34.60M$ 37.45M$ 23.35M$ 24.63M$ 23.73M
Stockholders Equity$ 18.74M$ 26.76M$ 15.41M$ 20.09M$ 31.44M
Cash Flow-
Free Cash Flow$ -11.96M$ -13.88M$ -6.79M$ -9.01M$ -13.79M
Operating Cash Flow$ -11.74M$ -14.00M$ -6.79M$ -9.01M$ -13.69M
Investing Cash Flow$ 2.21M$ -25.29M$ 1.65M$ -1.40M$ 1.07M
Financing Cash Flow$ -4.00K$ 42.77M$ 4.19M$ -3.78M$ 0.00
Currency in USD

Abeona Therapeutics Earnings and Revenue History

Abeona Therapeutics Debt to Assets

Abeona Therapeutics Cash Flow

Abeona Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis